Study Group: Prescribers of Januvia (sitagliptin phosphate) (?)
Council Members in this Study Group: 40
Request a survey with this Study Group
Leading Experts in this Study Group
Harold Bays, MD, FACPPresident and Medical Director
L-MARC Research Center
Harold Bays, MD, FACE, FACP, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...
Joseph Bass, MD, PhDDivision Head of Endocrinology and Metabolism
Evanston Northwestern Healthcare
Joseph Bass, MD, PhD, is Assistant Professor of Medicine and Neurobiology at Northwestern University in Illinois and Division Head of Endocrinology and Metabolism at Evanston Northwestern Healthcare. He is also the Director of a federally-funded basic research program on obesity, diabetes, and lipid...
Dean Traiger, MDPhysician
Physicians’ Primary Care of Southwest Florida,P.L.
Dean Traiger, MD, is the Owner of Physician's Primary Care of Southwest Florida. Dr. Traiger is board certified in Family Practice and specializes in general primary care across the continuum of pediatrics, adolescent, and adult and geriatric care. He is also focused on diabetes care, hypertension,...
Farhad Zangeneh, MDAssistant Clinical Professor of Medicine
THE GEORGE WASHINGTON UNIVERSITY - CC
Farhad Zangeneh, MD, is an Assistant Clinical Professor of Medicine at George Washington University School of Medicine in District of Columbia. He is on the board of directors of ACCE and recently contributed to the AACE Diabetes guidelines. He is the Medical Director of Endocrine, Diabetes and Osteoporosis...
Michael DempseyMedical Director
Johns Hopkins Diabetes Center at Suburban Hospital
Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
The recent finding that Byetta therapy decreased mortality in the ACCORD study needs to be replicated in studies designed to address that point. Even if it is replicated and statistically significant, it probably will not be true for the widely anticipated once weekly extended formulation...
Should bisphosphonates be stopped in patients who have been taking them for many years? Should they be used at all?
As exciting as the DURATION I study results have been, Roche's GLP-1 agonist is also looking good in earlier phase trials, and there are MANY competitors in this GLP-1 realm, as well as the gliptins (oral, with similar efficacy on glucose and A1c but without the dramatic weight loss), chomping at the...
This compound may have additiional benefit in type 2 diabetic patients, especially those with the cardiometabolic syndrome.
The recent findings regarding pioglitazone in a large, randomized, intravascular cardiac ultrasound study finally begin to show some indication of the expected efficacy for which many physicians chose to use the drug, i.e., to decrease cardiovascular disease or its progression. From...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Contract Research Organization, Independent/Small
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Physician - Division Head
- President
- Medical Director
- Director